2769753-53-7|(2S,4R)-1-((S)-3,3-Dimethyl-2-(5-(4-(5-((8-methyl-6-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)-7-oxo-5,6,7,8-tetrahydropyrimido[4,5-d]pyrimidin-2-yl)amino)pyridin-2-yl)piperazin-1-yl)pentanamido)butanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide|BLD Pharm

Une entreprise certifiée ISO 9001, 14001, 45001 sales@bldpharm.com

Recherche par mot clé Recherche de liste Recherche de structure

Monnaie :

Langue : Français |

Lieu :

Lieu

Americas

Europe

Asia Pacific

Africa & Middle East

|

Compte Déconnexion Connexion Favoris Chariot0

Accueil/ Life Science/ ADC-linkers/ ADC-linker/ DB-1113

DB-1113
(2S,4R)-1-((S)-3,3-Dimethyl-2-(5-(4-(5-((8-methyl-6-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)-7-oxo-5,6,7,8-tetrahydropyrimido[4,5-d]pyrimidin-2-yl)amino)pyridin-2-yl)piperazin-1-yl)pentanamido)butanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide
*Cold-chain transportation

CAS NO.： 2769753-53-7

Taille	Prix	Sale Price	Remise	Stock-US	Stock-IND	Stock-EU	Stock-Global	Quantité

How to Order +86-21-61629022 sales@bldpharm.com tech@bldpharm.com Catalog

The item is temporarily out of stock. Please leave your email address and we will inform you when we have it in stock.

How to Order

CONTRÔLE DE QUALITÉ Batch NO.:

INFORMATION PRODUIT

Infos de base
Sécurité

Nom du produit :	(2S,4R)-1-((S)-3,3-Dimethyl-2-(5-(4-(5-((8-methyl-6-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)-7-oxo-5,6,7,8-tetrahydropyrimido[4,5-d]pyrimidin-2-yl)amino)pyridin-2-yl)piperazin-1-yl)pentanamido)butanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide
CAS NO. :	2769753-53-7	Masse moléculaire :	1144.31
MDL NO. :	N/A	Pureté/Spécification :
Formule moléculaire :	C₅₉H₆₈F₃N₁₃O₆S	Stockage :	-
Point d'ébullition :	-

GHS Pictogram :
Signal Word :		Precautionary Statements :
UN# :	-	Class :	-
Hazard Statements :	-	Packing Group :	-

RELATED CATEGORIES

Inhibitors/Agonists Autophagy ULK

Inhibitors/Agonists Cell Cycle CDK

Inhibitors/Agonists Cell Cycle LIMK

Inhibitors/Agonists Immunology/Inflammation SIK

Inhibitors/Agonists MAPK/ERK Pathway HPK1

Inhibitors/Agonists Metabolic Enzyme Ferroptosis

Protein Tyrosine Kinase/RTK GAK

TGF-beta/Smad Bcr-Abl

PRODUITS CONNEXES

RECORDS HISTORIQUES